These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 30383490)
21. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352 [TBL] [Abstract][Full Text] [Related]
22. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889 [TBL] [Abstract][Full Text] [Related]
23. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. Chan B; Zacharin M J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531 [TBL] [Abstract][Full Text] [Related]
25. Craniofacial fibrous dysplasia: A 10-case series. Couturier A; Aumaître O; Gilain L; Jean B; Mom T; André M Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):229-235. PubMed ID: 28302454 [TBL] [Abstract][Full Text] [Related]
26. Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates. Majoor BCJ; Papapoulos SE; Dijkstra PDS; Fiocco M; Hamdy NAT; Appelman-Dijkstra NM J Clin Endocrinol Metab; 2019 Dec; 104(12):6069-6078. PubMed ID: 31390018 [TBL] [Abstract][Full Text] [Related]
27. Hyperthyroidism in McCune-Albright Syndrome - a case report. Rosinha P; Ramalho D; Rodrigues O; Sousa S; Alves C; Lopes J; Caetano JS; Mirante A J Pediatr Endocrinol Metab; 2023 Mar; 36(3):319-322. PubMed ID: 36351197 [TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C; J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621 [TBL] [Abstract][Full Text] [Related]
29. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. Zacharin M; O'Sullivan M J Pediatr; 2000 Sep; 137(3):403-9. PubMed ID: 10969268 [TBL] [Abstract][Full Text] [Related]
30. Craniofacial fibrous dysplasia and aneurismal bone cyst in a patient with McCune-Albright syndrome. A case report and review of the literature. Castro Castro J; Villa Fernández JM; Agulleiro Díaz JP Neurocirugia (Astur : Engl Ed); 2023; 34(5):268-272. PubMed ID: 36192338 [TBL] [Abstract][Full Text] [Related]
31. Polyostotic fibrous dysplasia (McCune-Albright) with rare multiple epiphyseal lesions in association with aneurysmal bone cyst and pathologic fracture. Burdiles A; Marín R; Klaber I; Solar A; Calderón M; Jara F; Kara F; Bazáes D Radiol Case Rep; 2021 Sep; 16(9):2719-2725. PubMed ID: 34336077 [TBL] [Abstract][Full Text] [Related]
32. Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction. Wu D; Ma J; Bao S; Guan H Rheumatol Int; 2015 Apr; 35(4):767-72. PubMed ID: 25230905 [TBL] [Abstract][Full Text] [Related]
33. A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study. Meier ME; Hagelstein-Rotman M; van de Ven AC; Van der Geest ICM; Donker O; Pichardo SEC; Hissink Muller PCE; van der Meeren SW; Dorleijn DMJ; Winter EM; van de Sande MAJ; Appelman-Dijkstra NM Orphanet J Rare Dis; 2022 Dec; 17(1):439. PubMed ID: 36528764 [TBL] [Abstract][Full Text] [Related]
34. Increasing serum alkaline phosphatase is associated with bone deformity progression for patients with polyostotic fibrous dysplasia. Wang J; Du Z; Li D; Yang R; XiaodongTang ; Yan T; Guo W J Orthop Surg Res; 2020 Dec; 15(1):583. PubMed ID: 33272306 [TBL] [Abstract][Full Text] [Related]
35. Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature. Ozdemir Kutbay N; Sarer Yurekli B; Kartal Baykan E; Baydur Sahin S; Saygili F Case Rep Endocrinol; 2015; 2015():670809. PubMed ID: 26171261 [TBL] [Abstract][Full Text] [Related]
37. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Isaia GC; Lala R; Defilippi C; Matarazzo P; Andreo M; Roggia C; Priolo G; de Sanctis C Calcif Tissue Int; 2002 Aug; 71(2):121-8. PubMed ID: 12200645 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of IL-6 in the treatment of fibrous dysplasia of bone: The randomized double-blind placebo-controlled TOCIDYS trial. Chapurlat R; Gensburger D; Trolliet C; Rouanet S; Mehsen-Cetre N; Orcel P Bone; 2022 Apr; 157():116343. PubMed ID: 35104665 [TBL] [Abstract][Full Text] [Related]
39. [McCune-Albright syndrome with hyperthyroidism: report of one case and review of literature]. Chen QM; Meng J Shanghai Kou Qiang Yi Xue; 2018 Aug; 27(4):445-448. PubMed ID: 30483720 [TBL] [Abstract][Full Text] [Related]
40. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. Plotkin H; Rauch F; Zeitlin L; Munns C; Travers R; Glorieux FH J Clin Endocrinol Metab; 2003 Oct; 88(10):4569-75. PubMed ID: 14557424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]